secwatch.observer — SEC 8-K summary
======================================

Issuer:     Khosla Ventures Acquisition Co. (—)
CIK:        0001841873
Form:       8-K
Filed at:   2023-05-17T23:59:59+00:00
Accession:  0001193125-23-146927
Event type: regulatory
Sentiment:  negative
Materiality: 0.30
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Khosla Ventures Acquisition receives Nasdaq non-compliance notice for compensation committee composition
--------------------------------------------------------------------------------

- On May 9, 2023, Nasdaq notified KVSA that it violates Listing Rule 5605 because director resignation left Compensation Committee with one member.
- Cure period expires on earlier of next annual stockholders' meeting or March 7, 2024; if meeting before Sept 5, 2023, then by Sept 5, 2023.
- Company must submit evidence of compliance by the cure deadline; states it expects to comply within the cure period.
- Non-compliance follows prior disclosed resignation of director Derek Anthony West from board and Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841873/000119312523146927/0001193125-23-146927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841873/000119312523146927/d491259d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-146927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer